Skip to content

DexCom

US · DXCM #635 by market cap Listed 2005
79.32 -0.87 -1.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Company notice
    DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.
    SEC · 2025/10/29
  • Rating change
    Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
    Market Newswire · 2026/10/15
  • Rating change
    Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $102
    Market Newswire · 2026/9/24
  • Company notice
    DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.
    SEC · 2026/6/2
  • Rating change
    Citi Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $105
    Market Newswire · 2026/8/14
  • Rating change
    Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $102
    Market Newswire · 2026/9/18
  • Rating change
    Barclays Initiates DexCom(DXCM.US) With Buy Rating, Announces Target Price $115
    Market Newswire · 2026/10/8
  • Rating change
    BTIG Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $96
    Market Newswire · 2026/10/12
  • Company notice
    DexCom | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.4%)
    SEC · 2024/12/7
  • Rating change
    TD Cowen Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $95
    Market Newswire · 2026/9/18
  • BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
    Market Newswire · 2026/11/19
  • Citi Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $105
    Market Newswire · 2026/10/21
  • A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $85 to $120
    Market Newswire · 2026/10/31
  • Rating change
    RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $105
    Market Newswire · 2026/10/1
  • Barclays Upgrades DexCom(DXCM.US) to Buy Rating, Raises Target Price to $115
    Market Newswire · 2026/10/7
  • Company notice
    DexCom | 3: Initial statement of beneficial ownership of securities-Director Ashley Euan A.
    SEC · 2025/10/29
  • Rating change
    RBC Capital Initiates DexCom(DXCM.US) With Buy Rating, Announces Target Price $105
    Market Newswire · 2026/10/3
  • Company notice
    DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.
    SEC · 2026/11/4
  • A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $95 to $120
    Market Newswire · 2026/10/30
  • Rating change
    Mizuho Securities Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $100
    Market Newswire · 2026/10/13
  • BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
    Market Newswire · 2026/10/23
  • Rating change
    Mizuho Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $95
    Market Newswire · 2026/8/4
  • Company notice
    DexCom | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.5%)
    SEC · 2024/1/26
  • Rating change
    Argus Research Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $96
    Market Newswire · 2026/8/4
  • Rating change
    A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $82 to $105
    Market Newswire · 2026/7/31

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.

DexCom discussion 0 comments

Add a comment